Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | ![]() Dr. Robert Rosenfeld is Now Offering Enhanced Oral Cancer ScreeningsBy: Dr. Robert Rosenfeld Oral Cancer is not a rare disease and unfortunately it is on the rise. This year, approximately 45,780 will be diagnosed with oral cancer in the United States alone. Due to late stage discovery, one American dies every hour from oral cancer. Dr. Rosenfeld uses an oral cancer-screening device, OralID, in efforts to discover oral cancers in their earliest stages. Currently, 63% of oral cancers are found in late stages (stage III, IV), resulting in a 5-year survival rate of less than 50%. Finding these abnormalities in much earlier stages can increase the 5-year survival rate up to 80-90%. Those interested in receiving an oral cancer screening or learning more about our advanced technology implemented at Dr. Robert Rosenfeld contact our office at 858-755-1189 and ask about our OralID screenings, or visit our website at Drbob@robertrosenfelddds.com. About Forward Science LLC Forward Science is a biotech company based in Houston, TX. OralID, Forward Science's flagship product, is an award winning oral cancer screening device that allows clinicians to Shine Light. Save Lives.™ by identifying abnormalities that may not be seen under traditional white light examinations. Forward Science quickly expanded its product portfolio in efforts to provide clinicians with a complete program to battle the rising trends of oral cancer. With the launch of the ID For Life™ Program, Forward Science has evolved into the industry leader for oral oncology. The ID For Life™ Program includes the following in an effort to change the trends for oral cancer: screening device (OralID), diagnostic tests (CytID, PathID, hpvID, phID), and treatment options (SalivaMAX). To learn more about Forward Science's ID For Life™ Program, or any of their products, visit www.ForwardScience.com or call 855-696-7254. End
|
|